Allyx Therapeutics, Inc.

Biotechnology company · New Haven, Connecticut, United States

Allyx Therapeutics, Inc. is a biotechnology company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2018. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $5.8 million in total, most recently in 2024. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2026.

www.allyxthera.comProfile compiled from public records. Is this your company? Request a correction or update

Allyx Therapeutics at a glance

Typebiotechnology company
HeadquartersNew Haven, Connecticut, United States
Earliest incorporation on record2018
Employees (per SBIR records)1
SEC CIK1865257

What does Allyx Therapeutics do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $5.8 million in total (2020 to 2024). NIH funding came from the National Institute on Aging.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $26.4 million sold (2026).

Frequently asked questions about Allyx Therapeutics

Where is Allyx Therapeutics headquartered?

Allyx Therapeutics, Inc. is headquartered in New Haven, Connecticut, United States.

What does Allyx Therapeutics do?

Allyx Therapeutics, Inc. is a biotechnology company.

When was Allyx Therapeutics founded?

The earliest incorporation on record for Allyx Therapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.